Jefferies analyst David Shang maintained a Hold rating on CSPC Pharmaceutical Group (CHJTF – Research Report) today and set a price target of HK$4.60. The company’s shares closed last Monday ...

The survey, conducted from December 1-7, 2024, showed that incumbent 2nd District Representative and gubernatorial candidate L-ray Villafuerte trailed in the polls among CSPC students’ governor ...

Overview: CSPC Pharmaceutical Group Limited is an investment holding company involved in the research, development, manufacture, and sale of pharmaceutical products across China and ...

Walmart’s latest brand and logo update has left some social media users baffled. On Jan. 13, the company announced in a press release on its website that it was launching a “comprehensive ...

Overview: CSPC Pharmaceutical Group Limited is an investment holding company involved in the research, development, manufacture, and sale of pharmaceutical products across China and internationally, ...

However, their new logo and concept have sparked controversy, with some netizens accusing them of plagiarising aespa's aesthetic. NJZ recently introduced their new group name and logo via their ...

The CEO of MetCredit, a national collection agency, is asking the campaign of Liberal leader hopeful Mark Carney to stop using a logo that looks uncannily similar to his company’s. This week ...

Of course, some criticize these modern logos as being copy-and-paste, minimalist and unoriginal. Those yearn to return to the unique logos of the 1990s and early 2000s, where the NFL used elements ...

We've been getting creative with the best logo makers for branding your business online. It's difficult to understate the importance of good logo design - it's the quickest way for customers and ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

AstraZeneca has joined the ranks of pharma companies seeking to bring drugs targeting lipoprotein(a) to market, paying $100 million upfront for rights to a drug developed by CSPC Pharmaceutical.